Severe vitamin d deficiency: A prerequisite for COPD responsiveness to vitamin D supplementation?

Annals of Internal Medicine

Volumn 156, Issue 2, 2012, Pages 156-158

  Gold, Diane R ^a   Manson, Joann E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CATHELICIDIN; COLECALCIFEROL; COLLAGEN; MATRIX METALLOPROTEINASE; POLYPEPTIDE ANTIBIOTIC AGENT; VITAMIN D;

ARTICLE; ASTHMA; BACTERIAL INFECTION; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; LUNG INFECTION; MORTALITY; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UPREGULATION; VIRUS INFECTION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WOUND HEALING;

EID: 84855824412     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-156-2-201201170-00013     Document Type: Article

References (20)

1. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al; TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775-89. [PMID: 17314337]
2. Janssens W, Lehouck A, Carremans C, Bouillon R, Mathieu C, Decramer M. Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med. 2009;179:630-6. [PMID: 19164701]
3. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 2007;29:1224-38. [PMID: 17540785]
4. Hiemstra PS. Defensins and cathelicidins in inflammatory lung disease: beyond antimicrobial activity. Biochem Soc Trans. 2006;34:276-8. [PMID: 16545093]
5. Koli K, Keski-Oja J. 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ. 2000;11:221-9. [PMID: 10775039]
6. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the Third National Health and Nutrition Examination Survey. Chest. 2005;128:3792-8. [PMID: 16354847]
7. Kunisaki KM, Niewoehner DE, Singh RJ, Connett JE. Vitamin D status and longitudinal lung function decline in the Lung Health Study. Eur Respir J. 2011; 37:238-43. [PMID: 20595151]
8. Kunisaki KM, Niewoehner DE, Connett JE; for the COPD Clinical Research Network. Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. Am J Respir Crit Care Med. 2011. [PMID: 22077070]
9. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53-8. [PMID: 21118827]
10. Institute of Medicine, Committee to Review Dietary Reference Intakes for Vitamin D, Calcium. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Pr; 2011.
11. Lehouck A, Mathieu C, Carremans C, Baeke F, Verhaegen J, Van Eldere J, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease. A randomized trial. Ann Intern Med. 2012;156:105-14.
12. Han MK, Kazerooni EA, Lynch DA, Liu LX, Murray S, Curtis JL, et al; COPDGene Investigators. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011; 261:274-82. [PMID: 21788524]
13. Bossé Y, Lemire M, Poon AH, Daley D, He JQ, Sandford A, et al. Asthma and genes encoding components of the vitamin D pathway. Respir Res. 2009; 10:98. [PMID: 19852851]
14. Raby BA, Lazarus R, Silverman EK, Lake S, Lange C, Wjst M, et al. Association of vitamin D receptor gene polymorphisms with childhood and adult asthma. Am J Respir Crit Care Med. 2004;170:1057-65. [PMID: 15282200]
15. Dimeloe S, Hawrylowicz C. A direct role for vitamin D-binding protein in the pathogenesis of COPD? [Editorial]. Thorax. 2011;66:189-90. [PMID: 21233481]
16. DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ. 2010;340:b5463. [PMID: 20068257]
17. Glendenning P, Zhu K, Inderjeeth C, Howat P, Lewis JR, Prince RL. Effects of three monthly oral 150,000 IU cholecalciferol supplementation on falls, mobility and muscle strength in older postmenopausal women: a randomised controlled trial. J Bone Miner Res. 2011. [PMID: 21956713]
18. Smith H, Anderson F, Raphael H, Maslin P, Crozier S, Cooper C. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women-a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford). 2007;46:1852-7. [PMID: 17998225]
19. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303:1815-22. [PMID: 20460620]
20. Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials. 2011. [PMID: 21986389]